Product Images Neomycin Polymyxin B Sulfates And Dexamethasone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Neomycin Polymyxin B Sulfates And Dexamethasone NDC 13985-028 by Mwi/vetone, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Dexamethasone (structural formula) - 01e58ae0 cdcf 4c1f bfb9 9d0fc3ebd002 01
Neomycin Sulfate (structural formula) - 01e58ae0 cdcf 4c1f bfb9 9d0fc3ebd002 02
Polymyxin B Sulfate (structural formula) - 01e58ae0 cdcf 4c1f bfb9 9d0fc3ebd002 03
This appears to be a chemical formula for polymyxin B and some of its derivatives. Polymyxin B is an antibiotic that is used to treat infections caused by certain bacteria. The formula includes abbreviations for certain amino acids and chemical compounds.*
Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension USP (Carton, 5 mL - MWI) - 01e58ae0 cdcf 4c1f bfb9 9d0fc3ebd002 04
Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension is a sterile drug provided in a 5mL container. It is used only for ophthalmic purposes and should be kept out of children's reach. Each milliliter of the suspension contains 35 mg of neomycin sulfate, the equivalent of neomycin, and 10,000 polymyxin B units, and other chemicals. The usual dosage and precautions are available in the package insert. The dropper should not touch any surface to prevent contamination of the suspension. The drug should be stored upright in a dry place at a temperature between 15°C and 30°C.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.